Organovo Holdings Inc. | Income Statement
Fiscal year is April-March. All values USD Thousands.
2014
2015
2016
2017
2018
2019
Sales/Revenue
379.00
571.00
1,483.00
4,230.00
4,603.00
3,091
Cost of Goods Sold (COGS) incl. D&A
387.00
-
-
1,530.70
2,297.00
1,465
Gross Income
8.00
-
-
2,699.40
2,306.00
1,626
SG&A Expense
20,641.00
30,396.00
39,311.00
41,274.40
37,577.00
28,900
EBIT
20,649.00
30,297.00
38,643.00
38,575.00
35,271.00
27,274
Unusual Expense
5,120.00
196.00
17.00
4.00
-
-
Non Operating Income/Expense
84.00
12.00
-
51.00
8.00
63
Interest Expense
13.00
1.00
-
-
-
-
Pretax Income
25,848.00
30,082.00
38,572.00
38,424.00
34,801.00
26,632
Income Tax
-
-
3.00
23.00
2.00
3
Consolidated Net Income
25,848.00
30,082.00
38,575.00
38,447.00
34,803.00
26,635
Net Income
25,848.00
30,082.00
38,575.00
38,447.00
34,803.00
26,635
Net Income After Extraordinaries
25,848.00
30,082.00
38,575.00
38,447.00
34,803.00
26,635
Net Income Available to Common
25,848.00
30,082.00
38,575.00
38,447.00
34,803.00
26,635
EPS (Basic)
0.35
0.38
0.43
0.39
0.32
0.23
Basic Shares Outstanding
73,139.60
79,650.10
90,057.40
97,763.00
107,244.00
115,379.90
EPS (Diluted)
0.35
0.38
0.43
0.39
0.32
0.23
Diluted Shares Outstanding
73,139.60
79,650.10
90,057.40
97,763.00
107,244.00
115,379.90
EBITDA
20,262.00
29,825.00
37,828.00
37,425.70
34,004.00
26,291
Non-Operating Interest Income
18.00
32.00
88.00
198.00
478.00
705
About Organovo Holdings
View Profile
